Your session is about to expire
← Back to Search
Laser and Radio Frequency Treatment for Skin Tightening
Study Summary
This trial is testing whether a laser and radio frequency treatment is safe and effective for skin conditions.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a history of heat-related diseases like recurrent Herpes Simplex in the treated area, unless you follow a special preventive treatment plan.You should avoid taking medications like ibuprofen or other NSAIDs one week before and after the treatment session.You have had any kind of injections or implants in the treated area within the past 9 months or during the study.You have had Botox injections in the area being treated within the past 6 months or during the study.You have an imbalance in your hormones, as determined by the doctor in charge.You have a serious health condition like heart problems, diabetes, or important brain-related disorders.You have used certain skin care products or supplements with strong ingredients in the past 2 months or during the study. You have also taken oral retinoids in the past 6 months.You have undergone any treatments using light, RF, or other devices on the area being treated within the past 6 months or during the study.You have a history of skin disorders that affect the outer layer of the skin or the deeper skin layers, especially if they involve collagen or blood vessels.You have a history of skin color changes, like darkening or lightening, that can be caused by certain conditions.You have a birthmark, tattoo, or permanent makeup in the area that will be treated.You have a history of keloid scarring or problems with healing wounds properly.
- Group 1: Diode Laser Treatment Only
- Group 2: Diode Laser and RadioFrequency Treatment
- Group 3: Multiple Diode Treatments
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there still an opportunity to take part in this research endeavor?
"Unfortunately, the data hosted on clinicaltrials.gov suggests that this medical study is not currently seeking candidates at this time. The trial was initially posted on July 1st 2020 and its last update occurred 25th April 2022. However, there are 185 other trials accepting applicants as we speak."
What is the hoped-for result of this experiment?
"The primary aim of this trial, measured on Day 1, 7, 14 and 20-30 post treatment is to assess the impact of treatment on collagen formation as determined by histology. Secondary outcomes include an assessment of elastin gene expression with biopsies taken prior to and after intervention; quantification of immune response related gene expression through biopsy sampling before and after therapy; and determination of changes in collagen levels via gene expression analysis from pre/post-treatment tissue samples."
Who qualifies as an appropriate participant for this research?
"Applicants who wish to join this clinical trial must have adiposis dolorosa and be between the ages of 21-60. A maximum of 9 participants are being accepted for the study."
Is the participant pool of this investigation inclusive of individuals aged 85 or above?
"The requirements for entering this medical trial state that the minimum age is 21 and no participant can be older than 60 years old."
Share this study with friends
Copy Link
Messenger